All Stories

  1. Histology of the Upper Gastrointestinal Tract, Morphometry and Lymphocyte Subpopulations of the Duodenal Mucosa: Insights from Healthy Individuals
  2. γδ+ T-Cells Is a Useful Biomarker for the Differential Diagnosis between Celiac Disease and Non-Celiac Gluten Sensitivity in Patients under Gluten Free Diet
  3. Improving the Diagnosis of Dermatitis Herpetiformis Using the Intraepithelial Lymphogram
  4. A Population-Based Cross-Sectional Study of Paediatric Coeliac Disease in Catalonia Showed a Downward Trend in Prevalence Compared to the Previous Decade
  5. Persistent villous atrophy predicts development of complications and mortality in adult patients with coeliac disease: a multicentre longitudinal cohort study and development of a score to identify high-risk patients
  6. Mucosal Interleukin‐10 depletion in steroid‐refractory Crohn's disease patients
  7. Carbohydrate Maldigestion and Intolerance
  8. Coeliac Disease in Elderly Patients: Value of Coeliac Lymphogram for Diagnosis
  9. Long-Term Effect of a Gluten-Free Diet on Diarrhoea- or Bloating-Predominant Functional Bowel Disease: Role of the ‘Low-Grade Coeliac Score’ and the ‘Coeliac Lymphogram’ in the Response Rate to the Diet
  10. Intraepithelial Lymphocyte Cytometric Pattern Is a Useful Diagnostic Tool for Coeliac Disease Diagnosis Irrespective of Degree of Mucosal Damage and Age—A Validation Cohort
  11. Predictive Value of Carcinoembryonic Antigen in Symptomatic Patients without Colorectal Cancer: A Post-Hoc Analysis within the COLONPREDICT Cohort
  12. Gamma delta+ intraepithelial lymphocytes and coeliac lymphogram in a diagnostic approach to coeliac disease in patients with seronegative villous atrophy
  13. Systematic Review and Meta-Analysis: Accuracy of Both Gamma Delta+ Intraepithelial Lymphocytes and Coeliac Lymphogram Evaluated by Flow Cytometry for Coeliac Disease Diagnosis
  14. Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study)
  15. A Scoring System for Identifying Patients Likely to Be Diagnosed with Low-Grade Coeliac Enteropathy
  16. Systematic review with meta-analysis: the prevalence of bile acid malabsorption and response to colestyramine in patients with chronic watery diarrhoea and previous cholecystectomy
  17. Case-finding of coeliac disease by using a POCT
  18. Post-Operative Morbidity and Mortality of a Cohort of Steroid Refractory Acute Severe Ulcerative Colitis: Nationwide Multicenter Study of the GETECCU ENEIDA Registry
  19. Study of the standard direct costs of various techniques of advanced endoscopy. Comparison with surgical alternatives
  20. Recommendations to report and interpret HLA genetic findings in coeliac disease
  21. Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989–2013): A Nationwide Multicenter Study
  22. Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment
  23. Letter: the definition of budesonide dependence in microscopic colitis
  24. Th1 Pathway: The Missing Link Between Inflammatory Bowel Disease and Microscopic Colitis?
  25. Corrigendum: Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients
  26. Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives
  27. Escasa eficacia de metronidazol en la erradicación de Blastocystis hominis en pacientes sintomáticos: serie de casos y revisión sistemática de la literatura
  28. Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia
  29. Systematic Review and Meta-analysis Show 3% of Patients With Celiac Disease in Spain to be Negative for HLA-DQ2.5 and HLA-DQ8
  30. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients
  31. Colitis microscópica: avances para una mejor identificación en los pacientes con diarrea crónica
  32. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients
  33. Diarrea crónica: definición, clasificación y diagnóstico
  34. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients
  35. Double-Blind Randomized Clinical Trial: Gluten versus Placebo Rechallenge in Patients with Lymphocytic Enteritis and Suspected Celiac Disease
  36. Letter: oral low-dose methotrexate for collagenous colitis - authors’ reply
  37. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases
  38. Immunological Differences between Lymphocytic and Collagenous Colitis
  39. Potential coeliac disease markers and autoimmunity in olmesartan induced enteropathy: A population-based study
  40. The low-FODMAP diet for irritable bowel syndrome: Lights and shadows
  41. Prevalence and Natural History of Microscopic Colitis: A Population-Based Study With Long-term Clinical Follow-up in Terrassa, Spain
  42. Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group
  43. Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer
  44. Endoscopic surveillance in patients with multiple (10–100) colorectal polyps
  45. Grado de adecuación de las indicaciones de la colonoscopia en una unidad de acceso abierto
  46. Randomised clinical trial: colestyramine vs. hydroxypropyl cellulose in patients with functional chronic watery diarrhoea
  47. Systematic review: noncoeliac gluten sensitivity
  48. Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: Multicenter prospective observational study (REPENTINA 3)
  49. Accuracy of GastroPanel for the diagnosis of atrophic gastritis
  50. Intestinal Intraepithelial Lymphocyte Cytometric Pattern Is More Accurate than Subepithelial Deposits of Anti-Tissue Transglutaminase IgA for the Diagnosis of Celiac Disease in Lymphocytic Enteritis
  51. Letter: persisting clinical symptoms in microscopic colitis in remission
  52. Sensibilidad al gluten no celiaca: una revisión crítica de la evidencia actual
  53. Budesonide Is More Effective Than Mesalamine or Placebo in Short-term Treatment of Collagenous Colitis
  54. Multiple Sporadic Colorectal Cancers Display a Unique Methylation Phenotype
  55. Prevalence and Characteristics ofMUTYH-Associated Polyposis in Patients with Multiple Adenomatous and Serrated Polyps
  56. Transcultural adaptation and validation of the Celiac Disease Quality of Life (CD-QOL) survey, a specific questionnaire to measure quality of life in patients with celiac disease
  57. Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility
  58. Clinical Subtypes and Molecular Characteristics of Serrated Polyposis Syndrome
  59. Impact of Current Smoking on the Clinical Course of Microscopic Colitis
  60. Genetic susceptibility variants associated with colorectal cancer prognosis
  61. Letter: mucosal healing and mortality in coeliac disease
  62. Comparison of lymphocyte isolation methods for endoscopic biopsy specimens from the colonic mucosa
  63. Lymphocytic Enteropathy, HLA-DQ2/DQ8 Genotype and Wheat-Dependent Symptoms: Non-Celiac Wheat Sensitivity or Marsh I Celiac Disease?
  64. Azathioprine and mercaptopurine in the management of patients with chronic, active microscopic colitis
  65. Letter: the role of stent in the treatment of Crohn's disease strictures - authors’ reply
  66. Helicobacter pyloriinfection as a cause of iron deficiency anaemia of unknown origin
  67. BMP2 / BMP4 colorectal cancer susceptibility loci in northern and southern European populations
  68. Comment to “High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of coeliac disease”
  69. Microscopic colitis: Current status, present and future challenges
  70. Are positive serum-IgA-tissue-transglutaminase antibodies enough to diagnose coeliac disease without a small bowel biopsy? Post-test probability of coeliac disease
  71. Is a gluten-free diet necessary in Marsh I intestinal lesions in patients with HLADQ2, DQ8 genotype and without gastrointestinal symptoms?
  72. Reliability of symptom analysis during carbohydrate hydrogen-breath tests
  73. Letter: are lymphocytic colitis and collagenous colitis really the same disease?
  74. Lymphocytic duodenosis: Aetiology and long-term response to specific treatment
  75. Prevalence and clinical relevance of enteropathy associated with systemic autoimmune diseases
  76. Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration
  77. Enteropatía sensible al gluten y dispepsia funcional
  78. Seeking genetic susceptibility variants for colorectal cancer: the EPICOLON consortium experience
  79. Susceptibility genetic variants associated with early-onset colorectal cancer
  80. Efficacy of anti-TNF therapies in refractory severe microscopic colitis
  81. Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins
  82. Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohnʼs disease
  83. Mild enteropathy as a cause of iron-deficiency anaemia of previously unknown origin
  84. Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: A population-based study
  85. Reply
  86. The prevalence of coeliac disease is significantly higher in children compared with adults
  87. Susceptibility Genetic Variants Associated With Colorectal Cancer Risk Correlate With Cancer Phenotype
  88. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy
  89. Características de los pacientes con poliposis adenomatosa familiar en España. Resultados iniciales del Registro Español de Poliposis Adenomatosa Familiar
  90. Aberrant Gene Promoter Methylation Associated with Sporadic Multiple Colorectal Cancer
  91. Fructose-sorbitol malabsorption
  92. Paucicellular Lymphocytic Colitis: Is It a Minor Form of Lymphocytic Colitis? A Clinical Pathological and Immunological Study
  93. ¿Existe la diarrea funcional? ¿Qué pruebas hay que realizar para llegar a otros diagnósticos?
  94. A short review of malabsorption and anemia
  95. Impact of mass screening for gluten-sensitive enteropathy in working population
  96. Lack of Clinical Usefulness of Das-1 Monoclonal Antibody and Mucin Expression as Risk Markers of Gastric Carcinoma in Patients With Gastric Intestinal Metaplasia
  97. How Do We Manage Vaccinations in Patients with Inflammatory Bowel Disease?
  98. Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study
  99. Pitfalls and errors in the diagnosis of collagenous and lymphocytic colitis
  100. Diagnostic value of duodenal antitissue transglutaminase antibodies in gluten-sensitive enteropathy
  101. Systematic Evaluation of the Causes of Chronic Watery Diarrhea With Functional Characteristics
  102. Detection of Metachronous Neoplasms in Colorectal Cancer Patients: Identification of Risk Factors
  103. Epidemiology of microscopic colitis * Authors' response
  104. How much symptom overlap is there between microscopic colitis and IBS?
  105. Drug Consumption and the Risk of Microscopic Colitis
  106. Spectrum of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease: clinical relevance of lymphocytic enteritis
  107. Sugar malabsorption in functional abdominal bloating: A pilot study on the long-term effect of dietary treatment
  108. Intestinal spirochetosis and chronic watery diarrhea: Clinical and histological response to treatment and long-term follow up
  109. Nutritional care of the patient with constipation
  110. Predisposing HLA-DQ2 and HLA-DQ8 haplotypes of coeliac disease and associated enteropathy in microscopic colitis
  111. Cribado de la enfermedad celíaca en grupos de riesgo
  112. Subepithelial myofibroblasts and tenascin expression in microscopic colitis
  113. Collagenous and lymphocytic colitis: evaluation of clinical and histological features, response to treatment, and long-term follow-up
  114. The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes
  115. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial
  116. Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status
  117. Effect of L-arginine on the course of experimental colitis
  118. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis
  119. Accuracy of an enzyme immunoassay for the detection of Helicobacter pylori in stool specimens in the diagnosis of infection and posttreatment check-up
  120. Reply
  121. Antineutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitis.
  122. Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis.
  123. Changes of the mucosal n3 and n6 fatty acid status occur early in the colorectal adenoma-carcinoma sequence.
  124. How Effective Is Enteral Nutrition in Inducing Clinical Remission in Active Crohn's Disease? A Meta-Analysis of the Randomized Clinical Trials
  125. Determinants of plasma fatty acid abnormalities in patients with active inflammatory bowel disease: A multivariate analysis
  126. Magnesium hydrogen breath test using end expiratory sampling to assess achlorhydria in pernicious anaemia patients.
  127. Accuracy of breath H2 criteria to detect carbohydrate malabsorbtion
  128. Enteral nutrition as primary therapy in Crohn's disease.
  129. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease.
  130. Reply
  131. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.
  132. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease.
  133. Plasma Polyunsaturated Fatty Acids in Liver Cirrhosis With or Without Chronic Hepatic Encephalopathy: A Preliminary Study
  134. Liver Function Tests Abnormalities in Patients with Inflammatory Bowel Disease Receiving Artificial Nutrition: A Prospective Randomized Study of Total Enteral Nutrition vs Total Parenteral Nutrition